Moshe Oren 个人学术档案 - 学术资源搜索

引用次数

	总计	2019 年至今
引用	84975	21566
h 指数	146	65
i10 指数	313	222

4300

2150

1075

3225

198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024254 202 219 306 358 654 907 1060 1334 1563 1485 1939 2036 2180 2360 2235 2204 2084 2054 2318 2020 2188 2274 2161 2656 2814 2850 2888 3163 2900 2905 2846 2941 3139 3635 4300 3970 3869 2643

开放获取的出版物数量

查看全部

81 篇文章

4 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

Ygal hauptDirector, Vittail Ltd在 vittail.com 的电子邮件经过验证
Efrat ShemaDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science在 weizmann.ac.il 的电子邮件经过验证
Tamar Juven-GershonPrincipal Investigator and Full Professor, The Mina and Everard Goodman Faculty of Life在 biu.ac.il 的电子邮件经过验证
Ben-Neriah, YHebrew University在 ekmd.huji.ac.il 的电子邮件经过验证
Doron GinsbergProfessor of Biology, Bar Ilan University在 biu.ac.il 的电子邮件经过验证
Tanya Gottlieb在 me-med.com 的电子邮件经过验证
Vassilis GorgoulisProfessor Histology-Embryology, Medical School, National Kapodistrian University of Athens在 med.uoa.gr 的电子邮件经过验证
Scott L. FriedmanProfessor of Medicine在 mssm.edu 的电子邮件经过验证
Ohad ShifmanIIBR在 iibr.gov.il 的电子邮件经过验证
Yosef ShilohTel Aviv University在 post.tau.ac.il 的电子邮件经过验证
Yosef ShaulProfessor of Biology, Weizmann Institute of Science在 weizmann.ac.il 的电子邮件经过验证
avri ben-ze'evProfessor of Molecular Cell Biology, Weizmann Institute of Science在 weizmann.ac.il 的电子邮件经过验证
Sheldon RowanAssistant Professor, Tufts University HNRCA在 tufts.edu 的电子邮件经过验证
Eytan DomanyWeizmann Institute of Science在 weizmann.ac.il 的电子邮件经过验证
Tomer CooksBen-Gurion University在 bgu.ac.il 的电子邮件经过验证
Ron RotkopfWeizmann Institute of Science在 weizmann.ac.il 的电子邮件经过验证
Eran KotlerStanford University在 stanford.edu 的电子邮件经过验证
Gerry MelinoUniversity Rome Tor Vergata, Italy & CDDpress, UK.在 uniroma2.it 的电子邮件经过验证
Peter GrussMax-Planck-Society and Okinawa Institute of Technology在 gv.mpg.de 的电子邮件经过验证
Siniša VolarevićSveučilište u Rijeci, Medicinski fakultet (University of Rijeka, Faculty of Medicine)在 medri.uniri.hr 的电子邮件经过验证

关注

Moshe Oren

Weizmann Institute of Science, Israel

在 weizmann.ac.il 的电子邮件经过验证

Cancer molecular biology cancer biology


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ... Cell Death & Differentiation 25 (3), 486-541, 2018	5713	2018
Mdm2 promotes the rapid degradation of p53 Y Haupt, R Maya, A Kazaz, M Oren Nature 387 (6630), 296-299, 1997	5600	1997
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 E Yonish-Rouach, D Resnftzky, J Lotem, L Sachs, A Kimchi, M Oren Nature 352 (6333), 345-347, 1991	2904	1991
The first 30 years of p53: growing ever more complex AJ Levine, M Oren Nature reviews cancer 9 (10), 749-758, 2009	2234	2009
mdm2 expression is induced by wild type p53 activity. Y Barak, T Juven, R Haffner, M Oren The EMBO journal 12 (2), 461-468, 1993	1849	1993
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis N Raver-Shapira, E Marciano, E Meiri, Y Spector, N Rosenfeld, ... Molecular cell 26 (5), 731-743, 2007	1643	2007
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life CA Finlay, PW Hinds, TH Tan, D Eliyahu, M Oren, AJ Levine Molecular and cellular biology, 1988	1523	1988
Decision making by p53: life, death and cancer M Oren Cell Death & Differentiation 10 (4), 431-442, 2003	1473	2003
Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis N Rivlin, R Brosh, M Oren, V Rotter Genes & cancer 2 (4), 466-474, 2011	1266	2011
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs M Müller, S Wilder, D Bannasch, D Israeli, K Lehlbach, M Li-Weber, ... The Journal of experimental medicine 188 (11), 2033-2045, 1998	1167	1998
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells D Eliyahu, A Raz, P Gruss, D Givol, M Oren Nature 312 (5995), 646-649, 1984	1105	1984
Wild-type p53 can inhibit oncogene-mediated focus formation. D Eliyahu, D Michalovitz, S Eliyahu, O Pinhasi-Kimhi, M Oren Proceedings of the National Academy of Sciences 86 (22), 8763-8767, 1989	1075	1989
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 D Michalovitz, O Halevy, M Oren Cell 62 (4), 671-680, 1990	1023	1990
The p53–Mdm2 module and the ubiquitin system D Michael, M Oren Seminars in cancer biology 13 (1), 49-58, 2003	1005	2003
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage R Maya, M Balass, ST Kim, D Shkedy, JFM Leal, O Shifman, M Moas, ... Genes & development 15 (9), 1067-1077, 2001	967	2001
Mutant p53 gain-of-function in cancer M Oren, V Rotter Cold Spring Harbor perspectives in biology 2 (2), a001107, 2010	951	2010
Extracellular vesicle and particle biomarkers define multiple human cancers A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ... Cell 182 (4), 1044-1061. e18, 2020	884	2020
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ... Cell Death & Differentiation 16 (8), 1093-1107, 2009	847	2009
Regulation of the p53 tumor suppressor protein M Oren Journal of Biological Chemistry 274 (51), 36031-36034, 1999	808	1999
Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Y Haupt, S Rowan, E Shaulian, KH Vousden, M Oren Genes & development 9 (17), 2170-2183, 1995	760	1995

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用